MIRAGEN THERAPEUTICS, INC. 4
4 · MIRAGEN THERAPEUTICS, INC. · Filed Mar 28, 2017
Insider Transaction Report
Form 4
Hughes Thomas E.
Director
Transactions
- Award
Stock Option (right to buy)
2017-03-24+1,191→ 1,191 totalExercise: $11.80Exp: 2027-03-23→ Common Stock (1,191 underlying) - Award
Common Stock
2017-03-24+778→ 14,840 total
Footnotes (2)
- [F1]Grant to the Reporting Person of a restricted stock award under the Issuer's 2016 Equity Incentive Plan (the "Plan"). The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan.
- [F2]Grant to the Reporting Person of a stock option under the Plan. The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant.